/KASE, May 6, 03/ - Himfarm OJSC (Shymkent), whose shares are circulating in Kazakhstan stock exchange's (KASE) official "B" listing category, provided KASE with the financial statement for 2002: the balance sheet, income statement and cash flow statement.

The following indicators are result of the issuer's financial and economic activity in 2002, based upon the issuer's data (in th. KZT, unless otherwise specified):

-------------------------------------------------------------------------
                                                As of      As of
Indicator                                  Jan 01, 02 Jan 01, 03 Change,%
------------------------------------------ ---------- ---------- --------
Issued (paid) authorized capital            1,557,675  1,557,675      0.0
Shareholders' equity                        1,626,161  1,856,974    +14.2
Total assets                                3,434,079  3,770,976     +9.8
Net working capital                            -1,620     56,029 +3,558.6
Accounts receivable                           308,732    377,204    +22.2
Total liabilities                           1,807,918  1,914,002     +5.9
Attracted credits                             811,700    724,863    -10.7
Accounts payable                              996,218  1,189,139    +19.4
Sales volume                                1,149,017  1,448,934    +26.1
Cost of goods sold                            830,938    973,987    +17.2
Net income for the period                      37,566     41,558    +10.6
------------------------------------------ ---------- ---------- --------
It's been calculated on the issuer's data:
------------------------------------------ ---------- ---------- --------
Return on sales (ROS), %                        27.68      32.78    +18.4
Return on equity (ROE), %                        2.31       2.24     -3.1
Return on assets (ROA), %                        1.09       1.10     +0.7
Book value of one share, KZT                   310.06     354.07    +14.2
Earnings per share (EPS), KZT                    7.31      8.13*    +11.2
Price earnings ratio (P/E), KZT                     -     11.13*        -
-------------------------------------------------------------------------

* - as of January 1 of 2003 earnings per share (EPS) and price earnings ratio (P/E) have been calculated without taking into account dividends on privileged shares, which will be determined at the company's annual general shareholders meeting.

Relative to 2001 there increase of:

• shareholders' equity - by KZT230.8 m. as the result of increase of additional unpaid capital by 195.6 m. and total sum of undistributed income - by 35.2 m.;
• assets - by KZT336.9 m., including: inventory - by 175.4 m., residual value of fixed assets - by 126.6 m. and other assets - by 34.9 m.;
• liabilities - by KZT106.1 m., that had been caused by increase of accounts payable by 192.9 m., whereas there took place decrease of attracted credits by KZT86.8 m.;
• sales volume - by KZT299.9 m.;
• cost of goods sold - by KZT143.0 m.;
• expenses of the period - by KZT122.5 m.

Net income, which Himfarm OJSC received in 2002, increased by KZT4.0 m. in comparison with 2001.

The tale below shows dynamics of sales volume and net income of Himfarm OJSC OJSC for 2002 by quarters by non-growing total (in th. KZT):

---------------------------------------------------------------------
                             Change,          Change,         Change,
Indicator     I-2002 II-2002       % III-2002       % IV-2002       %
------------ ------- ------- ------- -------- ------- ------- -------
Sales volume 492,707 242,956   -50.7  280,161   +15.3 433,110   +54.6
Net income     8,000  10,236   +28.0   11,600   +13.3  11,722    +1.1
---------------------------------------------------------------------

Company's primary activities - production of drugs; quality control and conducting of certification tests of drugs, ethyl alcohol and distillery production by the laboratory, which has passed accreditation; sale of chemical-pharmaceutical preparations, medical, sanitary-hygienic means and medical makings; preparation, purchasing of medical raw stuff;
production and sale of other goods.

[2003-05-12]